Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V. Long; Victoria Atkinson; Serigne Lo; Shahneen Sandhu; Alexander Guminski; Michael P. Brown; James S. Wilmott; Jarem Edwards; Maria Gonzalez; Richard A. Scolyer; Alexander M. Menzies; Grant A. McArthur

doi:10.1016/s1470-2045(18)30139-6

Related publications

Article2025

Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study

Georgina V. Long, Victoria Atkinson, Serigne Lo, Alexander Guminski, Shahneen Sandhu, Michael P. Brown, Maria Gonzalez, Grant A. McArthur, Alexander M Menzies

Article2016

A randomized phase 2 study of nivolumab and nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases: The Anti-PD1 Brain Collaboration (ABC Study).

Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Alexander Guminski, Shahneen Sandhu, Michael P. Brown, Tracy T.Y.E. Liaw, Maria Gonzalez, Jill Davison, Elizabeth Paton, Richard A. Scolyer, Louise Emmett, Grant A. McArthur

Article2017

A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC).

Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Serigne Lo, Alexander Guminski, Michael P. Brown, M. M. González, Katrina Diamante, Shahneen Sandhu, Richard A. Scolyer, Louise Emmett, Grant A. McArthur

Article2019

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C.J. van Akkooi, Chandra Mani Adhikari, Carolien Bierman, Bart A. van de Wiel, Richard A Scolyer, Oscar Krijgsman, Karolina Sikorska, Hanna Eriksson, Annegien Broeks, Johannes V. van Thienen, Alexander Guminski, Alex Torres Acosta, Sylvia ter Meulen, Anne Miek Koenen, Linda J.W. Bosch, Kerwin F. Shannon, Loes M. Pronk, Maria Gonzalez,

Article2021

Five-year overall survival from the anti-PD1 brain collaboration (ABC Study): Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets).

Georgina V. Long, Victoria Atkinson, Serigne Lo, Alexander Guminski, Shahneen Sandhu, Michael P. Brown, Maria Gonzalez, Richard A. Scolyer, Louise Emmett, Grant A. McArthur, Alexander M. Menzies